• IMMUNE NETWORK
• /
• 제16권1호
• /
• pp.44-51
• /
• 2016

Dendritic cells (DCs) are professional antigen presenting cells, and play an important role in the induction of antigen-specific adaptive immunity. However, some DC populations are involved in immune regulation and immune tolerance. These DC populations are believed to take part in the control of immune exaggeration and immune disorder, and maintain immune homeostasis in the body. Tolerogenic DCs (tolDCs) can be generated in vitro by genetic or pharmacological modification or by controlling the maturation stages of cytokine-derived DCs. These tolDCs have been investigated for the treatment of rheumatoid arthritis (RA) in experimental animal models. In the last decade, several in vitro and in vivo approaches have been translated into clinical trials. As of 2015, three tolDC trials for RA are on the list of ClinicalTrial.gov (www.clinicaltrials.gov). Other trials for RA are in progress and will be listed soon. In this review, we discuss the evolution of tolDC-based immunotherapy for RA and its limitations and future prospects.

• Journal of Microbiology and Biotechnology
• /
• 제34권6호
• /
• pp.1197-1205
• /
• 2024

Filamentous fungi are important cell factories for the production of high-value enzymes and chemicals for the food, chemical, and pharmaceutical industries. Under submerged fermentation, filamentous fungi exhibit diverse fungal morphologies that are influenced by environmental factors, which in turn affect the rheological properties and mass transfer of the fermentation system, and ultimately the synthesis of products. In this review, we first summarize the mechanisms of mycelial morphogenesis and then provide an overview of current developments in methods and strategies for morphological regulation, including physicochemical and metabolic engineering approaches. We also anticipate that rapid developments in synthetic biology and genetic manipulation tools will accelerate morphological engineering in the future.

• BMB Reports
• /
• 제36권1호
• /
• pp.78-81
• /
• 2003

The prevention of cancer is one of the most important public health and medical practices of the $21^{st}$ century. We have made much progress in this new emerging field, but so much remains to be accomplished before widespread use and practice become common place. Cancer chemoprevention encompasses the concepts of inhibition, reversal, and retardation of the cancer process. This process, called carcinogenesis, requires 20-40 years to reach the endpoint called invasive cancer. It typically follows multiple, diverse and complex pathways in a stochastic process of clonal evolution. These pathways appear amenable to inhibition, reversal or retardation at various points. We must therefore identify key pathways in the evolution of the cancer cell that can be exploited to prevent this carcinogenesis process. Basic research is identifying many genetic lesions and epigenetic processes associated with the progression of precancer to invasive disease. Many of these early precancerous lesions favor cell division over quiescence and protect cells against apoptosis when signals are present. Many oncogenes are active during early development and are reactivated in adulthood by aberrant gene promoting errors. Normal regulatory genes are mutated, making them insensitive to normal regulatory signals. Tumor suppressor genes are deleted or mutated rendering them inactive. Thus there is a wide range of defects in cellular machinery which can lead to evolution of the cancer phenotype. Mistakes may not have to appear in a certain order for cells to progress along the cancer pathway. To conquer this diverse disease, we must attack multiple key pathways at once for a predetermined period of time. Thus, agent combination prevention strategies are essential to decrease cancer morbidity. Furthermore, each cancer type may require custom combination of prevention strategies to be successful.

• Journal of Plant Biotechnology
• /
• 제36권3호
• /
• pp.207-213
• /
• 2009

Starch serves not only as an energy source for plants, animals, and humans but also as an environmentally friendly alternative for fossil fuels. Progress in understanding of starch biosynthesis, and the isolation of many genes involved in this process have enabled the genetic modification of crops in a rational manner to produce novel starches with improved functionality. Starch is composed of two glucose polymers, amylose and amylopectin. The amylose and amylopectin ratio in starch affects its physical and physicochemical properties. Alteration in starch structure can be achieved by modifying genes encoding the enzymes responsible for starch biosynthesis and starch hydrolysis. Here, we describe recent findings concerning the starch modification in sweetpotato. Sweetpotato [Ipomoea batatas (L.) Lam] ranks seventh in annual production among food crops in the world as an important starch source. To develop transgenic sweetpotato plants with modifying starch composition, we constructed transformation vectors overexpressing granule bound starch synthase I and inhibiting amylopectin synthesis genes such as starch branching enzyme and isoamylase under the control of 35S promoter, respectively. Transformation of sweetpotato (cv. Yulmi) is in progress.

• 생명과학회지
• /
• 제25권9호
• /
• pp.1059-1071
• /
• 2015

수박과 멜론은 경제적 중요성을 지니는 대표적인 박과 작물이다. 최근 유전자 지도 작성 및 차세대 유전체 염기서열 분석에 기반한 분자마커 개발과 염기서열변이 탐색은 마커 이용 선발 및 여교잡 등 분자육종을 통한 품종육성에 필수적 기술이다. 본 연구에서는 이들 작물에 대한 국내외 유전체 분석 과 분자마커 개발 현황에 대해 분석ㆍ정리함으로서 향후 분자육종에 활용할 수 있는 정보를 제공하고자 하였다. 수박과 멜론은 참조유전체의 염기서열이 밝혀졌으며 다수의 유전자 지도가 작성되어 수량, 과특성, 내병성과 같은 주요 형질과 연관된 마커의 개발과 관련 유전자의 탐색이 꾸준히 진행되고 있다. 현재까지 해외에서 보고된 유전자지도는 수박 멜론 각 각 16종 이상이며, 40개 이상의 주요형질에 대한 유전자좌와 연관 마커들이 존재한다. 더욱이 고밀도 유전자 지도와 유전자지도 기반 클로닝을 통해 이러한 형질을 조절하는 기능 유전자에 정보가 밝혀지고 있다. 또한 참조게놈정보를 기반으로 한 다양한 유전자원의 전장유전체염기서열 재분석이 꾸준히 이루어지고 있다. 새로운 분자마커의 자체적 개발과 더불어 이와 같이 현재 활용 가능한 공개된 마커들의 정보를 통해 유전체학 이용 육종과정을 크게 앞당길 수 있을 것이다.

• Journal of Plant Biotechnology
• /
• 제43권3호
• /
• pp.272-280
• /
• 2016

국화는 관상용, 약용으로 활용되는 주요한 화훼 작물중의 하나이다. 국화의 육종 프로그램은 다양한 품종의 개발에 기여하였으나, 다른 주요한 식량, 채소작물에서 보여졌듯이 전통적인 표현형 기반의 품종선발에서 분자표지를 활용한 선발로 진일보할 필요가 있다. 이러한 분자육종은 유전학, 분자생물학, 최근에는 유전체 연구로 규명된 형질연관 분자표지에 의존한다. 그러나 자가불화합성, 자식약세, 이질육배체, 이형접합성, 거대한 유전체와 같은 국화의 생식적, 유전적, 유전체의 특성으로 인하여 이러한 연구는 심각하게 지연되고 있다. 그럼에도 불구하고 유전연구를 통하여 국화의 유전자지도가 구축되었고 꽃, 잎, 식물구조와 같은 국화의 주요한 형질과 연관된 분자표지가 규명되었다. 염기서열 분석기술이 발달됨에 따라 국화의 전사체가 해독되어 국화의 표준유전자 목록이 구축되고 발달단계에 따라 혹은 생물적 비생물적 환경에서 특이적으로 발현되는 유전자도 규명되었다. 또한 2배체인 야생의 국화속 식물의 유전체 해독 프로젝트가 시작되었다. 이러한 대량의 염기서열 정보는 국화의 분자육종을 위한 근원적인 자원으로 활용될 수 있을 것이다. 이 총설에서는 국화의 분자유전학, 유전체 연구의 현황을 요약하고 향후 전망을 논의한다.

• 산업경영시스템학회지
• /
• 제41권1호
• /
• pp.102-109
• /
• 2018

This paper seeks to present a multi-control method that can contribute to effective control of the production line with multiple bottleneck processes. The multi-control method is the production system that complements shortcomings of CONWIP and DBR, and it is designed to determine the raw material input according to the WIP level of two bottleneck processes and WIP level of total process. The effectiveness of the production system developed by applying the multi-control method was verified by the following three procedures. Raw material input conditions of the multi-control method are as follows. First, raw materials are go into the production line when the number of the total process WIP is lower than established number of WIP in total process and first process is idle. Second, raw materials are introduced when the number of WIP of two bottleneck processes is lower than the established number of WIP of each bottleneck process. Third, raw materials are introduced when the first process and in front of bottleneck process are idle even if the number of WIP in the total process is less than established number of WIP of the total process. The production line with two bottleneck processes was selected as the condition for production environment, and the production process modeling of CONWIP, DBR and multi-control production method was defined according to the production condition. And the optimum limited WIP level suitable for each system was obtained by applying a genetic algorithm to determine the total limited number of WIP of CONWIP, the limited number of WIP of DBR bottleneck process, the number of WIP in the total process of multi-control method and the limited number of WIP of bottleneck process. The limited number of WIP of CONWIP, DBR and multi-control method obtained by the genetic algorithm were applied to ARENA modeling, which is simulation software, and a simulation was conducted to derive result values on the basis of three criteria such as production volume, lead time and number of goods in-progress.

• Environmental Analysis Health and Toxicology
• /
• 제14권1_2호
• /
• pp.1-12
• /
• 1999

Recently, several new methods for the detection of genetic damages in vitro and in vivo based on molecular biological techniques were introduced according to the rapid progress in toxicology combined with cellular and molecular biology. Among these methods, mouse lymphoma thymidine kanase (tk) gene forward mutation assay, single cell gel electrophoresis (comet assay) and transgenic animal and cell line model as a target gene of lac I (Big Blue) and lac Z (Muta Mouse) gene mutation are newly introduced based on molecular toxicological approaches. The mouse lymphoma tk$\^$+/-/ gene assay (MOLY) using L5178Y tk$\^$+/-/ mouse lymphoma cell line is one of the mammalian forward mutation assays, and has many advantages and more sensitive than hprt assay. The target gene of MOLY is a heterozygous tk$\^$+/-/ gene located in 11 chromosome, so it is able to detect the wide range of genetic changes like point mutation, deletion, rearrangement, and mitotic recombination within tk gene or deletion of entire chromosome 11. The comet assay is a rapid, simple, visual and sensitive technique for measuring and analysing DNA breakages in mammalian cells, Also, transgenic animal and cell line models, which have exogenous DNA incorporated into their genome, carry recoverable shuttle vector containing reporter genes to assess endogenous effects or alteration in specific genes related to disease process, are powerful tools to study the mechanism of mutation in vivo and in vitro, respectively. Also in vivo acridine orange supravital staining micronucleus assay by using mouse peripheral reticulocytes was introduced as an alternative of bone marrow micronucleus assay. In this respect, there was an International workshop on genotoxicity procedure (IWGTP) supported by OECD and EMS (Environmental Mutagen Society) at Washington D. C. in March 25-26, 1999. The objective of IWGTP is to harmonize the testing procedures internationally, and to extend to finalization of OECD guideline, and to the agreement of new guidelines under the International Conference of Harmonization (ICH) for these methods mentioned above. Therefore, we introduce and review the principle, detailed procedure, and application of MOLY, comet assay, transgenic mutagenesis assay and supravital staining micronucleus assay.

• Asian-Australasian Journal of Animal Sciences
• /
• 제23권8호
• /
• pp.981-986
• /
• 2010

Genetic parameters of growth traits were estimated in the German Angora rabbit reared in the sub-temperate region of India. Estimates of (co)variance components were obtained for body weights at weaning (42 days) and post-weaning at 84, 126 and 168 days. A total of 8,324 animal records were used for the analysis of these traits. The data were analyzed by restricted maximum likelihood (REML) fitting six animal models with various combinations of direct and maternal effects. A log likelihood ratio test was used to select the most appropriate univariate model for each trait. Direct heritability estimates were observed to be moderate for the traits under study. Heritability estimates for weaning (42 d), 84, 126 and 168 d weights obtained from the best models were $0.25{\pm}0.05$, $0.17{\pm}0.05$, $0.21{\pm}0.06$ and $0.12{\pm}0.05$. Maternal effects had higher importance at weaning, and declined with the advancement of age. Significant maternal permanent environmental effect on weaning and post-weaning weights was a carryover effect of maternal influences during pre-weaning age. The estimated repeatabilities of doe effects on body weights were 0.37, 0.22, 0.18 and 0.28 at weaning, 84, 126 and 168 d body weight, respectively. Results indicated that modest rate of genetic progress is possible for body weight traits of Angora rabbit through selection. Similarly, these growth traits could be included in selection criteria along with wool traits for early selection of the animals.

• Journal of Pharmaceutical Investigation
• /
• 제32권3호
• /
• pp.153-159
• /
• 2002

Gene therapy is fundamentally a sophisticated drug delivery technology to cure a disease by the transfer of genetic material to modify living cells. In other words, the gene is used as a therapeutic drug much like a chemical compound is employed in chemotherapy. Currently almost 600 clinical trials are underway worldwide since the first clinical trials carried out in 1990 to treat adenosine deaminase deficiency using retroviral vectors. Despite the great progress still is there no gene therapy product being approved as a new drug. This is partly due to a lack of an ideal gene delivery system that is safe and can provide stable, optimal level production of the therapeutic proteins in the cell. This review covers the current status of several different biological and physico-chemical agents that are being developed as gene delivery vehicles. Although gene therapy promises great hopes toward the cure of a broad spectrum of genetic and acquired diseases, the success of gene therapy heavily asks for the development of vector systems for safe and efficient application in humans.